FEATURES OF SPECIFIC PREVENTION OF INFECTIOUS DISEASES IN SERVICE DOGS
DOI:
https://doi.org/10.37000/abbsl.2021.101.02Keywords:
dogs, vaccination, Nobivac, Eurican, infectious diseasesAbstract
Preventive vaccinations is the most important in the system of specific prevention of infectious diseases in dogs. Vaccination of puppies begins at the age of 8-10 weeks, when the effect of maternal antibodies on the components of the vaccine is minimal. Deworming should be carried out 10 days before vaccination. Nobivac KC vaccine can be used to vaccinate puppies from 3 weeks of age. From the age of 4 weeks, special vaccines are used, such as: Nobivac Puppy DP, Nobivac Puppy DP. Nobivac Rabies vaccine is used to prevent rabies from 8 weeks of age. Vaccination of puppies with Vanguard vaccines can be started from 6 weeks of age. Veterinary specialists of canine units for prophylactic vaccinations recommend the use of the Eurican DHPPI2 + L and DHPPI2 + LR vaccine, manufactured by "Merial", France, when using this vaccine a long-term intense immunity develops in dogs.
References
On approval of the Instruction on the organization of activity of cynological divisions of National police of Ukraine: Order of the Ministry of Internal Affairs of Ukraine No 1145 dated November 1, 2016. URL: https://zakon.rada.gov.ua/laws/show/z1544-16.
Greene, C. E. (2006). Infectious diseases of the dog and cat (No. Ed. 3). WB SaundersElsevier Science.
Ford, R. B., Larson, L. J., McClure, K. D., Schultz, R. D., & Welborn, L. V. (2017). 2017 AAHA canine vaccination guidelines. Journal of the American Animal Hospital Association, 53(5), 243-251.
De Cramer, K. G. M., Stylianides, E., & Van Vuuren, M. (2011). Efficacy of vaccination at 4 and 6 weeks in the control of canine parvovirus. Veterinary microbiology, 149(1-2), 126-132.
Vojtek, B., Mojžišová, J., Smrčo, P., & Drážovská, M. (2017). Effects of orally administered β–1, 3/1, 6–glucan on vaccination responses and immunological parameters in dogs. Food and agricultural immunology, 28(6), 993-1002.
Tizard, I. R. (2021). Canine vaccines. Vaccines for Veterinarians, 153.
Dodds, W. J., Logemann, J. A., & Stewart, E. T. (1990). Radiologic assessment of abnormal oral and pharyngeal phases of swallowing. AJR. American journal of roentgenology, 154(5), 965-974.
Woma, T. Y., van Vuuren, M., Bosman, A. M., Quan, M., & Oosthuizen, M. (2010). Phylogenetic analysis of the haemagglutinin gene of current wild-type canine distemper viruses from South Africa: lineage Africa. Veterinary microbiology, 143(2-4), 126-132.
Spibey, N., Greenwood, N. M., Sutton, D., Chalmers, W. S. K., & Tarpey, I. (2008). Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus. Veterinary microbiology, 128(1-2), 48-55.
Klaasen, H. L. B. M., Molkenboer, M. J. C. H., Vrijenhoek, M. P., & Kaashoek, M. J. (2003). Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine. Veterinary microbiology, 95(1-2), 121-132.
Andre‐Fontaine, G., Branger, C., Gray, A. W., & Klaasen, H. L. B. M. (2003). Comparison of the efficacy of three commercial bacterins in preventing canine leptospirosis. Veterinary record, 153(6), 165-169.
Minke, J. M., Bouvet, J., Cliquet, F., Wasniewski, M., Guiot, A. L., Lemaitre, L., ... & Guigal, P. M. (2009). Comparison of antibody responses after vaccination with two inactivated rabies vaccines. Veterinary microbiology, 133(3), 283-286.
Rikula, U., Nuotio, L., & Sihvonen, L. (2000). Canine distemper virus neutralising antibodies in vaccinated dogs. Veterinary Record, 147(21), 598-603.
Spiri, A. M., Rodriguez-Campos, S., Matos, J. M., Glaus, T. M., Riond, B., Reusch, C. E., ... & Willi, B. (2017). Clinical, serological and echocardiographic examination of healthy field dogs before and after vaccination with a commercial tetravalent leptospirosis vaccine. BMC veterinary research, 13(1), 1-10.
Vila Nova, B., Cunha, E., Sepúlveda, N., Oliveira, M., São Braz, B., Tavares, L., & Gil, S. (2018). Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study. BMC veterinary research, 14(1), 1-8.
Minke, J. M., Bey, R., Tronel, J. P., Latour, S., Colombet, G., Yvorel, J., ... & Guigal, P. M. (2009). Onset and duration of protective immunity against clinical disease and renal carriage in dogs provided by a bi-valent inactivated leptospirosis vaccine. Veterinary microbiology, 137(1-2), 137-145.
Taweethavonsawat, P., Chungpivat, S., Satranarakun, P., Traub, R. J., & Schaper, R. (2010). Efficacy of a combination product containing pyrantel, febantel and praziquantel (Drontal® Plus Flavour, Bayer Animal Health) against experimental infection with the hookworm Ancylostoma ceylanicum in dogs. Parasitology research, 106(2), 533-537.
Sowman, H. R., N. J. Cave, and M. Dunowska. "A survey of canine respiratory pathogens in New Zealand dogs." New Zealand veterinary journal 66.5 (2018): 236-242.
Spibey, N., Greenwood, N. M., Sutton, D., Chalmers, W. S. K., & Tarpey, I. (2008). Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus. Veterinary microbiology, 128(1-2), 48-55.
Harrus, S. (2020). Canine Vaccination Guidelines in Israel. Israel Journal of Veterinary Medicine, 75, 3.
